One explanation could be that low or high activation levels of TLR4/MyD88 signaling lead to significantly different expression levels of specific TLR4/MyD88 target genes, which in turn would affect the tumor infiltration capacity in opposing ways. This evidence concerns the gene TLR4 and neoplasm.